Incyte (INCY) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 47.10% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 140.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 140.88% |
| Dec 31, 2025 | 119.08% |
| Sep 30, 2025 | 55.52% |
| Jun 30, 2025 | 35.88% |
| Mar 31, 2025 | 60.88% |
| Dec 31, 2024 | -29.07% |
| Sep 30, 2024 | -16.33% |
| Jun 30, 2024 | -70.71% |
| Mar 31, 2024 | 46.85% |
| Dec 31, 2023 | 10.30% |
| Sep 30, 2023 | 136.72% |
| Jun 30, 2023 | -11.16% |
| Mar 31, 2023 | 26.62% |
| Dec 31, 2022 | -36.47% |
| Sep 30, 2022 | -4.20% |
| Jun 30, 2022 | 15.30% |
| Mar 31, 2022 | -28.12% |
| Dec 31, 2021 | 101.36% |
| Sep 30, 2021 | 84.00% |
| Jun 30, 2021 | 41.82% |
| Mar 31, 2021 | 48.90% |
| Dec 31, 2020 | 44.25% |
| Sep 30, 2020 | -34.29% |
| Jun 30, 2020 | 193.39% |
| Mar 31, 2020 | -56.76% |
| Dec 31, 2019 | 132.14% |
| Sep 30, 2019 | 51.52% |
| Jun 30, 2019 | 45.17% |
| Mar 31, 2019 | 62.04% |
| Dec 31, 2018 | 7.77% |
| Sep 30, 2018 | 39.88% |
| Jun 30, 2018 | 77.98% |
| Mar 31, 2018 | -30.86% |
| Dec 31, 2017 | -59.40% |
| Sep 30, 2017 | -15.28% |
| Jun 30, 2017 | 30.30% |
| Mar 31, 2017 | -76.62% |
| Dec 31, 2016 | 30.20% |
| Sep 30, 2016 | 54.30% |
| Jun 30, 2016 | 148.74% |
| Mar 31, 2016 | 52.33% |
| Dec 31, 2015 | 43.23% |
| Sep 30, 2015 | -22.16% |
| Jun 30, 2015 | 32.04% |
| Mar 31, 2015 | 26.07% |
| Dec 31, 2014 | 12.46% |
| Sep 30, 2014 | 46.08% |
| Jun 30, 2014 | 10.75% |
| Mar 31, 2014 | -8.60% |
| Dec 31, 2013 | -49.14% |
| Sep 30, 2013 | 11.42% |
| Jun 30, 2013 | -41.69% |
| Mar 31, 2013 | 24.02% |